{"id":77480,"date":"2015-03-17T17:18:00","date_gmt":"2015-03-17T17:18:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/"},"modified":"2015-03-17T17:18:00","modified_gmt":"2015-03-17T17:18:00","slug":"que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/","title":{"rendered":"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d&#8217;exclusi\u00f3 social?"},"content":{"rendered":"<p>\u00a0<\/p>\n<ul>\n<li><strong>A aquestes preguntes es donar\u00e0 resposta durant el Congr\u00e9s i Sal\u00f3 Europeu d\u2019Oficina de Farm\u00e0cia Infarma Barcelona 2015. Concretament la primera la contestar\u00e0 el cardi\u00f2leg Josep Brugada, expert mundial en mort sobtada i un dels impulsors de la instal\u00b7laci\u00f3 de desfibril\u00b7ladors a les farm\u00e0cies de Barcelona<\/strong><\/li>\n<li><strong>Els nous serveis al pacient que ofereixen de forma creixent les farm\u00e0cies tindran una pres\u00e8ncia destacada: entre d\u2019altres xifres, es presentaran els resultats del programa pioner de detecci\u00f3 del risc cardiovascular des de la farm\u00e0cia <\/strong><\/li>\n<li><strong>Tamb\u00e9 es far\u00e0 un rep\u00e0s a  la situaci\u00f3 de programes, com el d\u2019Atenci\u00f3 Farmac\u00e8utica al Pacient Cr\u00f2nic Complex, i a projectes, com per exemple Radars <\/strong><br \/>\u00a0<\/li>\n<\/ul>\n<p><i>Barcelona, 17 de mar\u00e7 de 2015.-<\/i><span> Falta just una setmana per a qu\u00e8 comenci <\/span><b>Infarma Barcelona 2015<\/b><span>, punt de trobada del sector farmac\u00e8utic <\/span><span>organitzat conjuntament pels<\/span><b> <\/b><span>Col\u00b7legis de Farmac\u00e8utics de Madrid i Barcelona, amb la col\u00b7laboraci\u00f3 d\u2019Interalia, que tindr\u00e0 lloc els propers <\/span><b><u>24, 25 i 26 de mar\u00e7 al recinte firal de Gran Via<\/u><\/b><span>. <\/span><span>Durant els tres dies <\/span><b>m\u00e9s de 220 ponents d\u2019\u00e0mbit nacional i internacional<\/b><span> es donaran cita per parlar, mitjan\u00e7ant les <\/span><b>10 taules de debat i m\u00e9s de 60<\/b><span> <\/span><b>aules actives, dels nous serveis que ofereixen les farm\u00e0cies al pacient de forma creixent<\/b><span>, aix\u00ed com <\/span><b>debatre l\u2019actualitat i les perspectives del sector<\/b><span> en el marc del lema escollit per a aquesta 27a edici\u00f3: <\/span><b>\u201cOrientats a l\u2019acci\u00f3. Experi\u00e8ncies per millorar la farm\u00e0cia des del present\u201d. <\/b><span>El programa complet es pot consultar al web d\u2019Infarma a trav\u00e9s <\/span><a href=\"http:\/\/www.infarma.es\/ca\/web\/infarma-2015\/programa\">d\u2019aquest enlla\u00e7<\/a><span>.<\/span><\/p>\n<p class=\"MsoNormal\">\n<p class=\"MsoNormal\"><b><u>Prevenci\u00f3 del risc cardiovascular, atenci\u00f3 farmac\u00e8utica al pacient cr\u00f2nic complex, detecci\u00f3 preco\u00e7 del VIH i c\u00e0ncer de c\u00f2lon, alguns dels serveis que presten les farm\u00e0cies<\/p>\n<p><\/u><\/b><\/p>\n<p class=\"MsoNormal\">A la taula <b>\u201cServeis farmac\u00e8utics de prevenci\u00f3 i atenci\u00f3 al pacient\u201d, <\/b>s\u2019explicaran diferents serveis professionals que s\u2019estan prestant a les farm\u00e0cies de diferents \u00e0mbits geogr\u00e0fics, alguns d\u2019ells concertats amb el sistema p\u00fablic de salut i altres des de l\u2019\u00e0mbit privat, com ara <b>l\u2019atenci\u00f3 farmac\u00e8utica al pacient cr\u00f2nic complex, i tamb\u00e9 es presentaran <\/b>els <b>resultats del<\/b> <b>programa pioner de detecci\u00f3 de risc cardiovascular en qu\u00e8 participen les farm\u00e0cies<\/b>, que va comen\u00e7ar fa un any. Un debat m\u00e9s ampli s\u2019abordar\u00e0 a la confer\u00e8ncia <b>\u201cLa farm\u00e0cia i la salut p\u00fablica\u201d.<\/b><\/p>\n<p class=\"MsoNormal\">La prevenci\u00f3 del risc cardiovascular tamb\u00e9 estar\u00e0 present a la <b>confer\u00e8ncia inaugural, a c\u00e0rrec del cardi\u00f2leg Josep Brugada, expert mundial en mort sobtada, on s\u2019aprofundir\u00e0 en el rol que poden <\/b><b>desenvolupar els farmac\u00e8utics en aquest \u00e0mbit. <\/b>Brugada \u00e9s <span>professor de la Facultat de Medicina de la UB, cardi\u00f2leg de l\u2019Hospital Cl\u00ednic de Barcelona, cap de secci\u00f3 d\u2019Ar\u00edtmies Pedi\u00e0triques de l\u2019Hospital Sant Joan de D\u00e9u i un dels impulsors, des de l\u2019Associaci\u00f3 Barcelona Salut i juntament amb l\u2019Associaci\u00f3 de Farm\u00e0cies de Barcelona i la col\u00b7laboraci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona, de <b>la instal\u00b7laci\u00f3 de desfibril\u00b7ladors a les farm\u00e0cies de Barcelona, gr\u00e0cies als quals s\u2019han aconseguit salvar ja dues vides.<\/b> <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\">Un altre exemple d\u2019\u00e8xit de col\u00b7laboraci\u00f3 de la farm\u00e0cia en la xarxa sanit\u00e0ria \u00e9s el projecte <b>Radars<\/b> \u2013creat amb l\u2019objectiu de detectar i ajudar a persones grans en risc d\u2019a\u00efllament\u2013 del qual se\u2019n parlar\u00e0 a l\u2019aula activa <b>\u201cEl farmac\u00e8utic comprom\u00e8s amb la societat\u201d. <\/b>Les aules actives estan centrades en aprofundir coneixements en les \u00e0rees d\u2019especialitzaci\u00f3 de la farm\u00e0cia i en aquesta edici\u00f3 alguns dels temes seran<b> qu\u00e8 s\u2019ha de tenir en compte per aconsellar sobre esport des de la farm\u00e0cia i com pot ajudar la fitoter\u00e0pia en el tractament coadjuvant del c\u00e0ncer.<\/b><\/p>\n<p class=\"MsoNormal\"><u><b>Aquests i altres temes d\u2019estricta actualitat tindran el seu espai al Congr\u00e9s, en destaquem alguns a la seg\u00fcent graella i els trobareu tots al programa:\u00a0<\/b><\/u><b><\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.cofb.org\/image\/image_gallery?uuid=5371dc43-9a71-43f0-a45b-0aaf6fa7cf38&amp;groupId=10136&amp;t=1426611579866\" width=\"400\" height=\"448\" alt=\"\"><\/p>\n<p><\/b><u><strong>Infarma en xifres:<\/strong><\/u><strong><br \/><img decoding=\"async\" src=\"https:\/\/www.cofb.org\/image\/image_gallery?uuid=3025372f-9963-4808-ac83-05af23969047&amp;groupId=10136&amp;t=1426608841032\" width=\"400\" height=\"139\" alt=\"\"><br type=\"_moz\"><\/strong><\/p>\n<p class=\"MsoNormal\"><strong>Ja podeu SOL\u00b7LICITAR UNA ACREDITACI\u00d3, nom\u00e9s cal confirmar assist\u00e8ncia al Departament de Comunicaci\u00f3 del COFB enviant un correu electr\u00f2nic a <a href=\"javascript:location.href='mailto:'+String.fromCharCode(112,114,101,109,115,97,64,99,111,102,98,46,110,101,116,32)+'?'\">premsa@cofb.net <\/a><\/strong><\/p>\n<p class=\"MsoNormal\"><strong>Per a m\u00e9s informaci\u00f3:<\/strong><\/p>\n<p>Departament de Comunicaci\u00f3 INFARMA Barcelona 2015<\/p>\n<p>Contacte: 93 244 07 28 \/ 18 \/ premsa@cofb.net<\/p>\n<p>Web d\u2019Infarma: <a href=\"http:\/\/www.infarma.es\/\" target=\"_blank\" rel=\"noopener\">www.infarma.es<\/a>. Twitter: <a href=\"https:\/\/twitter.com\/infarma_es\" target=\"_blank\" rel=\"noopener\">@Infarma_es <\/a><strong><br \/><\/strong><\/p>\n<p class=\"MsoNormal\"><b><\/p>\n<p><\/b><\/p>\n<p>\u00a0A aquestes preguntes es donar\u00e0 resposta durant el Congr\u00e9s i Sal\u00f3 Europeu d\u2019Oficina de Farm\u00e0cia Infarma Barcelona 2015. Concretament la primera la contestar\u00e0 el cardi\u00f2leg Josep Brugada, expert mundial en mort sobtada i un dels impulsors de la instal\u00b7laci\u00f3 de desfibril\u00b7ladors a les farm\u00e0cies de BarcelonaEls nous serveis al pacient que ofereixen de forma creixent les farm\u00e0cies tindran una pres\u00e8ncia destacada: entre d\u2019altres xifres, es presentaran els resultats del programa pioner de detecci\u00f3 del risc cardiovascular des de la farm\u00e0cia Tamb\u00e9 es far\u00e0 un rep\u00e0s a  la situaci\u00f3 de programes, com el d\u2019Atenci\u00f3 Farmac\u00e8utica al Pacient Cr\u00f2nic Complex, i a projectes, com per exemple Radars \u00a0Barcelona, 17 de mar\u00e7 de 2015.- Falta just una setmana per a qu\u00e8 comenci Infarma Barcelona 2015, punt de trobada del sector farmac\u00e8utic organitzat conjuntament pels Col\u00b7legis de Farmac\u00e8utics de Madrid i Barcelona, amb la col\u00b7laboraci\u00f3 d\u2019Interalia, que tindr\u00e0 lloc els propers 24, 25 i 26 de mar\u00e7 al recinte firal de Gran Via. Durant els tres dies m\u00e9s de 220 ponents d\u2019\u00e0mbit nacional i internacional es donaran cita per parlar, mitjan\u00e7ant les 10 taules de debat i m\u00e9s de 60 aules actives, dels nous serveis que ofereixen les farm\u00e0cies al pacient de forma creixent, aix\u00ed com debatre l\u2019actualitat i les perspectives del sector en el marc del lema escollit per a aquesta 27a edici\u00f3: \u201cOrientats a l\u2019acci\u00f3. Experi\u00e8ncies per millorar la farm\u00e0cia des del present\u201d. El programa complet es pot consultar al web d\u2019Infarma a trav\u00e9s d\u2019aquest enlla\u00e7.  Prevenci\u00f3 del risc cardiovascular, atenci\u00f3 farmac\u00e8utica al pacient cr\u00f2nic complex, detecci\u00f3 preco\u00e7 del VIH i c\u00e0ncer de c\u00f2lon, alguns dels serveis que presten les farm\u00e0cies  A la taula \u201cServeis farmac\u00e8utics de prevenci\u00f3 i atenci\u00f3 al pacient\u201d, s\u2019explicaran diferents serveis professionals que s\u2019estan prestant a les farm\u00e0cies de diferents \u00e0mbits geogr\u00e0fics, alguns d\u2019ells concertats amb el sistema p\u00fablic de salut i altres des de l\u2019\u00e0mbit privat, com ara l\u2019atenci\u00f3 farmac\u00e8utica al pacient cr\u00f2nic complex, i tamb\u00e9 es presentaran els resultats del programa pioner de detecci\u00f3 de risc cardiovascular en qu\u00e8 participen les farm\u00e0cies, que va comen\u00e7ar fa un any. Un debat m\u00e9s ampli s\u2019abordar\u00e0 a la confer\u00e8ncia \u201cLa farm\u00e0cia i la salut p\u00fablica\u201d.  La prevenci\u00f3 del risc cardiovascular tamb\u00e9 estar\u00e0 present a la confer\u00e8ncia inaugural, a c\u00e0rrec del cardi\u00f2leg Josep Brugada, expert mundial en mort sobtada, on s\u2019aprofundir\u00e0 en el rol que poden desenvolupar els farmac\u00e8utics en aquest \u00e0mbit. Brugada \u00e9s professor de la Facultat de Medicina de la UB, cardi\u00f2leg de l\u2019Hospital Cl\u00ednic de Barcelona, cap de secci\u00f3 d\u2019Ar\u00edtmies Pedi\u00e0triques de l\u2019Hospital Sant Joan de D\u00e9u i un dels impulsors, des de l\u2019Associaci\u00f3 Barcelona Salut i juntament amb l\u2019Associaci\u00f3 de Farm\u00e0cies de Barcelona i la col\u00b7laboraci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona, de la instal\u00b7laci\u00f3 de desfibril\u00b7ladors a les farm\u00e0cies de Barcelona, gr\u00e0cies als quals s\u2019han aconseguit salvar ja dues vides.   Un altre exemple d\u2019\u00e8xit de col\u00b7laboraci\u00f3 de la farm\u00e0cia en la xarxa sanit\u00e0ria \u00e9s el projecte Radars \u2013creat amb l\u2019objectiu de detectar i ajudar a persones grans en risc d\u2019a\u00efllament\u2013 del qual se\u2019n parlar\u00e0 a l\u2019aula activa \u201cEl farmac\u00e8utic comprom\u00e8s amb la societat\u201d. Les aules actives estan centrades en aprofundir coneixements en les \u00e0rees d\u2019especialitzaci\u00f3 de la farm\u00e0cia i en aquesta edici\u00f3 alguns dels temes seran qu\u00e8 s\u2019ha de tenir en compte per aconsellar sobre esport des de la farm\u00e0cia i com pot ajudar la fitoter\u00e0pia en el tractament coadjuvant del c\u00e0ncer.Aquests i altres temes d\u2019estricta actualitat tindran el seu espai al Congr\u00e9s, en destaquem alguns a la seg\u00fcent graella i els trobareu tots al programa:\u00a0Infarma en xifres:Ja podeu SOL\u00b7LICITAR UNA ACREDITACI\u00d3, nom\u00e9s cal confirmar assist\u00e8ncia al Departament de Comunicaci\u00f3 del COFB enviant un correu electr\u00f2nic a premsa@cofb.net Per a m\u00e9s informaci\u00f3:Departament de Comunicaci\u00f3 INFARMA Barcelona 2015Contacte: 93 244 07 28 \/ 18 \/ premsa@cofb.net Web d\u2019Infarma: www.infarma.es. Twitter: @Infarma_es\u00a0\u00a0COFB.ORG<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 A aquestes preguntes es donar\u00e0 resposta durant el Congr\u00e9s i Sal\u00f3 Europeu d\u2019Oficina de Farm\u00e0cia Infarma Barcelona 2015. Concretament la primera la contestar\u00e0 el cardi\u00f2leg Josep Brugada, expert mundial en mort sobtada i un dels impulsors de la instal\u00b7laci\u00f3 de desfibril\u00b7ladors a les farm\u00e0cies de Barcelona Els nous serveis [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":77481,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77480","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d&#039;exclusi\u00f3 social? - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d&#039;exclusi\u00f3 social? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 A aquestes preguntes es donar\u00e0 resposta durant el Congr\u00e9s i Sal\u00f3 Europeu d\u2019Oficina de Farm\u00e0cia Infarma Barcelona 2015. Concretament la primera la contestar\u00e0 el cardi\u00f2leg Josep Brugada, expert mundial en mort sobtada i un dels impulsors de la instal\u00b7laci\u00f3 de desfibril\u00b7ladors a les farm\u00e0cies de Barcelona Els nous serveis [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-03-17T17:18:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"530\" \/>\n\t<meta property=\"og:image:height\" content=\"593\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d&#8217;exclusi\u00f3 social?\",\"datePublished\":\"2015-03-17T17:18:00+00:00\",\"dateModified\":\"2015-03-17T17:18:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/\"},\"wordCount\":1481,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg\",\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/\",\"name\":\"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d'exclusi\u00f3 social? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg\",\"datePublished\":\"2015-03-17T17:18:00+00:00\",\"dateModified\":\"2015-03-17T17:18:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg\",\"width\":530,\"height\":593},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d&#8217;exclusi\u00f3 social?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d'exclusi\u00f3 social? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/","og_locale":"ca_ES","og_type":"article","og_title":"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d'exclusi\u00f3 social? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 A aquestes preguntes es donar\u00e0 resposta durant el Congr\u00e9s i Sal\u00f3 Europeu d\u2019Oficina de Farm\u00e0cia Infarma Barcelona 2015. Concretament la primera la contestar\u00e0 el cardi\u00f2leg Josep Brugada, expert mundial en mort sobtada i un dels impulsors de la instal\u00b7laci\u00f3 de desfibril\u00b7ladors a les farm\u00e0cies de Barcelona Els nous serveis [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-03-17T17:18:00+00:00","og_image":[{"width":530,"height":593,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"7 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d&#8217;exclusi\u00f3 social?","datePublished":"2015-03-17T17:18:00+00:00","dateModified":"2015-03-17T17:18:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/"},"wordCount":1481,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg","articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/","url":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/","name":"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d'exclusi\u00f3 social? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg","datePublished":"2015-03-17T17:18:00+00:00","dateModified":"2015-03-17T17:18:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg","width":530,"height":593},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/17\/que-poden-aportar-els-farmaceutics-en-la-prevencio-cardiovascular-i-en-les-malalties-croniques-i-en-la-deteccio-de-persones-grans-en-risc-dexclusio-social\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Qu\u00e8 poden aportar els farmac\u00e8utics en la prevenci\u00f3 cardiovascular? I en les malalties cr\u00f2niques? I en la detecci\u00f3 de persones grans en risc d&#8217;exclusi\u00f3 social?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg",530,593,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj-150x150.jpeg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj-268x300.jpeg",268,300,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg",530,593,false],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg",530,593,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg",530,593,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj.jpeg",530,593,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2015\/03\/image_gallery-AY01Hj-11x12.jpeg",11,12,true]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 A aquestes preguntes es donar\u00e0 resposta durant el Congr\u00e9s i Sal\u00f3 Europeu d\u2019Oficina de Farm\u00e0cia Infarma Barcelona 2015. Concretament la primera la contestar\u00e0 el cardi\u00f2leg Josep Brugada, expert mundial en mort sobtada i un dels impulsors de la instal\u00b7laci\u00f3 de desfibril\u00b7ladors a les farm\u00e0cies de Barcelona Els nous serveis [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77480"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77480\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/77481"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}